These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27022873)

  • 1. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.
    Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V
    Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
    Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
    Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder.
    Sharma M; Sharma S; Wadhwa J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):45-55. PubMed ID: 30663410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis.
    Huguet-Casquero A; Xu Y; Gainza E; Pedraz JL; Beloqui A
    Int J Pharm; 2020 Aug; 586():119515. PubMed ID: 32544520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
    Yadav VR; Suresh S; Devi K; Yadav S
    J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
    Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
    Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases.
    Plaza-Oliver M; Beloqui A; Santander-Ortega MJ; Castro-Vázquez L; Rodríguez-Robledo V; Arroyo-Jiménez MM; Préat V; Lozano MV
    Int J Pharm; 2020 Aug; 586():119533. PubMed ID: 32534160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
    Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
    Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG; Mahajan HS
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery.
    Rapalli VK; Kaul V; Gorantla S; Waghule T; Dubey SK; Pandey MM; Singhvi G
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 224():117392. PubMed ID: 31330421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
    Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
    Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.